Low‐molecular‐weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study
Authors:
- 9 May 2012
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 119 (8) , 1008-1013
Abstract
Please cite this paper as: Basude S, Hein C, Curtis S, Clark A, Trinder J. Low‐molecular‐weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study. BJOG 2012;119:1008–1013.The management of anticoagulation in pregnant women with mechanical heart valves is complex. The maternal and fetal outcomes of 32 pregnancies in 15 women on three different anticoagulation regimens were compared. Anticoagulation with low‐molecular‐weight heparin (n = 4), warfarin (n = 22) and combination therapy (n = 6) resulted in adverse maternal events in four (100%), three (50%) and three (14%) women, and resulted in fetal losses in one (25%), 17(77%) and three (50%) pregnancies, respectively. Whereas the rate of fetal loss in the warfarin group was high, all women in the LMWH and half of those in the combination group had serious adverse maternal events, including valve thrombosis, maternal death and postpartum haemorrhage.Keywords
This publication has 10 references indexed in Scilit:
- Mechanical valve prosthesis and anticoagulation regimens in pregnancy: a tertiary centre experienceEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)European Heart Journal, 2011
- The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valvesObstetric Medicine, 2011
- Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experienceHaematologica, 2009
- Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparinBJOG: An International Journal of Obstetrics & Gynaecology, 2009
- Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and PregnancyChest, 2008
- Guidelines on the management of valvular heart disease: replyEuropean Heart Journal, 2007
- A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulationAmerican Journal of Obstetrics and Gynecology, 2004
- Anticoagulation in Pregnant Women With Prosthetic Heart ValvesJournal of Cardiovascular Pharmacology and Therapeutics, 2004
- Low-molecular-weight heparins: pharmacologic profile and product differentiationThe American Journal of Cardiology, 1998